ARCHIVES

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

This article is from The Cancer Letter archive.

Vol. 38 No. 12 | March 23, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh

January 1, 1988

CCI Gets Qualified Approval To Continue

January 18, 1980

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Univ. Of Washington, Fox Chase, ICC Win CCRU, CCSP Awards

July 8, 1983

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012